🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

7+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 7 of 7 recruiting trials for “Primary mediastinal large B-cell lymphoma”

Phase 1Enrolling by InvitationNCT07168486 ↗

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

👨‍⚕️ Djordje Atanackovic, MD, Professor of Medicine📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06500273 ↗

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

👨‍⚕️ Allogene Study Director, Allogene Therapeutics, Inc.📍 61 sites📅 Started Jun 2024View details ↗
Phase 1RecruitingNCT05653271 ↗

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

🏥 Acepodia Biotech, Inc.📍 13 sites📅 Started Jan 2023View details ↗
RecruitingNCT05366569 ↗

Bio-CAR-T BS Study

🏥 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia📍 1 site📅 Started Apr 2022View details ↗
Phase 2RecruitingNCT04745949 ↗

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

👨‍⚕️ Ranjit Nair, M.D. Anderson Cancer Center📍 1 site📅 Started May 2021View details ↗
NARecruitingNCT04824950 ↗

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

👨‍⚕️ VINCENT CAMUS, MD, Centre Henri Becquerel📍 2 sites📅 Started Mar 2021View details ↗
RecruitingNCT06339255 ↗

Italian Observational Study on CAR-T Therapy for Lymphoma

🏥 Paolo Corradini📍 1 site📅 Started Oct 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →